Publication
“Do State Bans of Most-Favored-Nation Contract Clauses Restrain Price Growth? Evidence From Hospital Prices”
Daniel R. Arnold, Katherine L. Gudiksen, Jaime S. King, Brent D. Fulton, Richard M. Scheffler
May 11, 2022
Most-favored-nation (MFN) contract clauses have recently garnered attention from both Congress and state legislatures looking for ways to curtail market power abuses in health care and rein in prices. In health care, a typical MFN contract clause is stipulated by the insurer and requires a health care provider to grant the insurer the lowest (i.e., the most-favored) price among the insurers it contracts with. As of August 2020, 20 states restrict the use of MFN clauses in health care contracts (19 states ban their use in at least some health care contracts), with 8 states prohibiting their use between 2010 and 2016.
Source Sightings
As Hospitals Grow, So Does Your Bill
Jaime S King, Katherine L Gudiksen, Thomas L Greaney
June 6, 2024
New evidence on the impacts of cross-market hospital mergers on commercial prices and measures of quality
Jaime S. King, Katie Gudiksen, Thomas L. Greaney
April 23, 2024
Pharma Litigation Threatens to Limit State Drug Pricing Policy
Katie Gudiksen
January 30, 2024
Models for Enhanced Health Care Market Oversight
Katie Gudiksen
January 25, 2024
How Will Draft Merger Guidelines Impact Health Care Markets?
Amy Gu, Katie Gudiksen, Jaime King
December 13, 2023